MMSI — Merit Medical Systems Income Statement
0.000.00%
Last trade - 00:00
- $4.28bn
- $4.52bn
- $1.26bn
- 87
- 27
- 75
- 67
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 995 | 964 | 1,075 | 1,151 | 1,257 |
Cost of Revenue | |||||
Gross Profit | 432 | 401 | 485 | 519 | 584 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 979 | 965 | 1,014 | 1,063 | 1,133 |
Operating Profit | 15.4 | -1.56 | 60.9 | 87.6 | 124 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 2.19 | -13.2 | 53.9 | 82.6 | 112 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5.45 | -9.84 | 48.5 | 74.5 | 94.4 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 5.45 | -9.84 | 48.5 | 74.5 | 94.4 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5.45 | -9.84 | 48.5 | 74.5 | 94.4 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.534 | 0.47 | 1.07 | 1.33 | 1.69 |